NCT03030911View on ClinicalTrials.gov

Dexmedetomidine vs Midazolam on Resting Energy Expenditure in Critically Ill Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

March 10, 2018

Study Completion Date

March 15, 2018

Conditions
Mechanical VentilationDexmedetomidineMidazolamSedation
Interventions
DRUG

Dexmedetomidine

The drug will be administered for sedation and its effect on basal metabolic rate will be investigated

DRUG

Midazolam

The drug will be administered for sedation and its effect on basal metabolic rate will be investigated

DRUG

Fentanyl

The drug will be administered in both groups

DEVICE

Indirect calorimetry

The device will be used for measurement of basal metabolic rate

Trial Locations (1)

Unknown

Cairo University, Cairo

All Listed Sponsors
lead

Cairo University

OTHER

NCT03030911 - Dexmedetomidine vs Midazolam on Resting Energy Expenditure in Critically Ill Patients | Biotech Hunter | Biotech Hunter